These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31382986)

  • 1. Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan.
    Lo SN; Hong AM; Haydu LE; Ahmed T; Paton EJ; Steel V; Hruby G; Tran A; Morton RL; Nowak AK; Vardy JL; Drummond KJ; Dhillon HM; Mandel C; Scolyer RA; Middleton MR; Burmeister BH; Thompson JF; Fogarty GB
    Trials; 2019 Aug; 20(1):477. PubMed ID: 31382986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan.
    Lo SN; Smit AK; Espinoza D; Cust AE;
    Trials; 2020 Jun; 21(1):594. PubMed ID: 32605576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole brain radiotherapy after local treatment of brain metastases in melanoma patients--a randomised phase III trial.
    Fogarty G; Morton RL; Vardy J; Nowak AK; Mandel C; Forder PM; Hong A; Hruby G; Burmeister B; Shivalingam B; Dhillon H; Thompson JF
    BMC Cancer; 2011 Apr; 11():142. PubMed ID: 21496312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial.
    Bartula I; Tran AD; Nowak AK; Ahmed T; Morton RL; Burmeister BH; Dolven-Jacobsen K; Nobes J; Thompson JF; Fogarty GB; Lo SN; Hong AM
    Clin Transl Radiat Oncol; 2023 Jul; 41():100597. PubMed ID: 37441544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality.
    Fogarty GB; Hong A; Dolven-Jacobsen K; Reisse CH; Burmeister B; Haydu LH; Dhillon H; Steel V; Shivalingam B; Drummond K; Vardy J; Nowak A; Hruby G; Scolyer RA; Mandel C; Thompson JF
    BMC Res Notes; 2015 May; 8():192. PubMed ID: 25952979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial.
    Hong AM; Fogarty GB; Dolven-Jacobsen K; Burmeister BH; Lo SN; Haydu LE; Vardy JL; Nowak AK; Dhillon HM; Ahmed T; Shivalingam B; Long GV; Menzies AM; Hruby G; Drummond KJ; Mandel C; Middleton MR; Reisse CH; Paton EJ; Steel V; Williams NC; Scolyer RA; Morton RL; Thompson JF
    J Clin Oncol; 2019 Nov; 37(33):3132-3141. PubMed ID: 31553661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
    Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
    BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.
    Fogarty GB; Hong A; Jacobsen KD; Reisse CH; Shivalingam B; Burmeister B; Haydu LE; Paton E; Thompson JF
    BMC Res Notes; 2014 Jun; 7():412. PubMed ID: 24981506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low incidence of melanoma brain metastasis in the hippocampus.
    Hong AM; Suo C; Valenzuela M; Haydu LE; Jacobsen KD; Reisse CH; Fogarty G
    Radiother Oncol; 2014 Apr; 111(1):59-62. PubMed ID: 24560764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
    Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosurgery versus surgery, both with adjuvant whole brain radiotherapy, for solitary brain metastases: a randomised controlled trial.
    Roos DE; Smith JG; Stephens SW
    Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):646-51. PubMed ID: 21592754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial.
    Zhang X; Wang T; Wang CY; Zhao P; Huang B; He L; Song YQ
    Trials; 2022 Oct; 23(1):876. PubMed ID: 36242060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
    Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
    Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI-prospective, multi-center one-arm study.
    Nawrocki S; Sugajska A
    BMC Cancer; 2020 Mar; 20(1):231. PubMed ID: 32188425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
    Williams NL; Wuthrick EJ; Kim H; Palmer JD; Garg S; Eldredge-Hindy H; Daskalakis C; Feeney KJ; Mastrangelo MJ; Kim LJ; Sato T; Kendra KL; Olencki T; Liebner DA; Farrell CJ; Evans JJ; Judy KD; Andrews DW; Dicker AP; Werner-Wasik M; Shi W
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):22-30. PubMed ID: 28816150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole brain radiotherapy for the treatment of multiple brain metastases.
    Tsao MN; Lloyd N; Wong R; Chow E; Rakovitch E; Laperriere N
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003869. PubMed ID: 16856022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.